198 related articles for article (PubMed ID: 31605739)
1. Variable impact of an antimicrobial stewardship programme in three intensive care units: time-series analysis of 2012-2017 surveillance data.
Abbara S; Domenech de Cellès M; Batista R; Mira JP; Poyart C; Poupet H; Casetta A; Kernéis S
J Hosp Infect; 2020 Feb; 104(2):150-157. PubMed ID: 31605739
[TBL] [Abstract][Full Text] [Related]
2. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
[TBL] [Abstract][Full Text] [Related]
3. Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU.
Abdallah M; Badawi M; Amirah MF; Rasheed A; Mady AF; Alodat M; Alharthy A
J Antimicrob Chemother; 2017 Nov; 72(11):3187-3190. PubMed ID: 28961733
[TBL] [Abstract][Full Text] [Related]
4. Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
Hwang H; Kim B
Sci Rep; 2018 Oct; 8(1):14757. PubMed ID: 30283084
[TBL] [Abstract][Full Text] [Related]
5. What Is the More Effective Antibiotic Stewardship Intervention: Preprescription Authorization or Postprescription Review With Feedback?
Tamma PD; Avdic E; Keenan JF; Zhao Y; Anand G; Cooper J; Dezube R; Hsu S; Cosgrove SE
Clin Infect Dis; 2017 Mar; 64(5):537-543. PubMed ID: 27927861
[TBL] [Abstract][Full Text] [Related]
6. Carbapenem-Nonsusceptible
Asempa TE; Nicolau DP; Kuti JL
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31118271
[No Abstract] [Full Text] [Related]
7. The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study.
Carmeli Y; Lidji SK; Shabtai E; Navon-Venezia S; Schwaber MJ
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):367-72. PubMed ID: 21683268
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa is not just in the intensive care unit any more: implications for empirical therapy.
Eagye KJ; Banevicius MA; Nicolau DP
Crit Care Med; 2012 Apr; 40(4):1329-32. PubMed ID: 22425824
[TBL] [Abstract][Full Text] [Related]
9. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.
Mladenovic-Antic S; Kocic B; Velickovic-Radovanovic R; Dinic M; Petrovic J; Randjelovic G; Mitic R
J Clin Pharm Ther; 2016 Oct; 41(5):532-7. PubMed ID: 27511808
[TBL] [Abstract][Full Text] [Related]
10. Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010.
Muraki Y; Kitamura M; Maeda Y; Kitahara T; Mori T; Ikeue H; Tsugita M; Tadano K; Takada K; Akamatsu T; Yamada T; Yamada T; Shiraishi T; Okuda M
Infection; 2013 Apr; 41(2):415-23. PubMed ID: 23471823
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for hospitalized patients with resistant or multidrug-resistant
Raman G; Avendano EE; Chan J; Merchant S; Puzniak L
Antimicrob Resist Infect Control; 2018; 7():79. PubMed ID: 29997889
[TBL] [Abstract][Full Text] [Related]
12. The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis.
Onorato L; Macera M; Calò F; Monari C; Russo F; Iovene MR; Signoriello G; Annibale R; Pace MC; Aurilio C; Gaeta GB; Coppola N
Clin Microbiol Infect; 2020 Jun; 26(6):782.e1-782.e6. PubMed ID: 31678230
[TBL] [Abstract][Full Text] [Related]
13. Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis.
Baditoiu L; Axente C; Lungeanu D; Muntean D; Horhat F; Moldovan R; Hogea E; Bedreag O; Sandesc D; Licker M
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):71. PubMed ID: 29132352
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa.
Fujimura S; Nakano Y; Sato T; Shirahata K; Watanabe A
J Infect Chemother; 2007 Jun; 13(3):147-50. PubMed ID: 17593500
[TBL] [Abstract][Full Text] [Related]
15. A new carbapenem drug dosage metric for carbapenem usage and correlation with carbapenem resistance of Pseudomonas aeruginosa.
Hirayama S; Yasui K; Murakami H; Kosugi T; Sakamoto M; Hanai Y; Matsuo K; Miyazaki T; Ishii Y; Nishizawa K; Tateda K
J Infect Chemother; 2018 Dec; 24(12):949-953. PubMed ID: 30268412
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial stewardship impact on Pseudomonas aeruginosa susceptibility to meropenem at a tertiary pediatric institution.
Stultz JS; Arnold SR; Shelton CM; Bagga B; Lee KR
Am J Infect Control; 2019 Dec; 47(12):1513-1515. PubMed ID: 31253550
[TBL] [Abstract][Full Text] [Related]
17. The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units.
Zou Y; Lian J; Di Y; You H; Yao H; Liu J; Dong Y
Int J Clin Pharm; 2018 Feb; 40(1):175-182. PubMed ID: 29134489
[TBL] [Abstract][Full Text] [Related]
18. Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates.
Pires dos Santos R; Jacoby T; Pires Machado D; Lisboa T; Gastal SL; Nagel FM; Kuplich NM; Konkewicz L; Gorniak Lovatto C; Pires MR; Goldani LZ
Infect Control Hosp Epidemiol; 2011 Jun; 32(6):584-90. PubMed ID: 21558771
[TBL] [Abstract][Full Text] [Related]
19. Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
Croughs PD; Klaassen CHW; van Rosmalen J; Maghdid DM; Boers SA; Hays JP; Goessens WHF;
Int J Antimicrob Agents; 2018 Sep; 52(3):407-410. PubMed ID: 29772393
[TBL] [Abstract][Full Text] [Related]
20. Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units.
Lewis GJ; Fang X; Gooch M; Cook PP
Infect Control Hosp Epidemiol; 2012 Apr; 33(4):368-73. PubMed ID: 22418632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
